Glycemic Control Using Intrinsic Factor Bound to A Vitamin B12 Conjugate of a Glucagon-Like Peptide-1 Receptor Agonist

• 收藏
• 分享

专利权人:

Syracuse University;Xeragenx LLC

发明人:

Robert Doyle,Jonathan D. Bortz,David S. Hermelin

申请号：

US15575468

公开号：

US20180154007A1

申请日:

2016.05.20

申请国别(地区):

US

年份:

2018

代理人:

摘要：

The present invention provides compositions and methods for lowering blood glucose. More specifically, the present invention provides compositions comprising a complex comprising IF and B12 conjugated to a peptide comprising a GLP-1 agonist. Advantageously, the composition may be delivered subcutaneously.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/